A preliminary study of ECT2 as a novel biomarker for assessing liver fibrosis and prognosis in biliary atresia - Top-Institutions - MDSpire

A preliminary study of ECT2 as a novel biomarker for assessing liver fibrosis and prognosis in biliary atresia

  • By

  • Yuqiang Chen

  • Xin Li

  • Qianhui Yang

  • Yu Meng

  • Alimujiang Abudureyimu

  • Jianghua Zhan

  • June 29, 2026

  • 0 min

Share

Top Institutions in Pediatrics

Brief introduction explaining scope and methodology.

  • #1

    Cincinnati Children’s Hospital Medical Center
    Cincinnati Children’s Hospital Medical Center

    Cincinnati, Ohio

    Key Differentiators

    • Pediatric Gastroenterology
    • Hepatology

  • #2

    Texas Children’s Hospital/Baylor College of Medicine
    Texas Children’s Hospital/Baylor College of Medicine

    Houston, Texas

    Key Differentiators

    • Pediatric Gastroenterology
    • Hepatology

  • #3

    University of Bonn
    University of Bonn

    Bonn, Germany

    Key Differentiators

    • Hepatology

  • #4

    Children’s Hospital at Montefiore
    Children’s Hospital at Montefiore

    Bronx, New York

    Key Differentiators

    • Pediatric Gastroenterology
    • Hepatology

  • #5

    Hopital Beaujon
    Hopital Beaujon

    Clichy, France

    Key Differentiators

    • Hepatology

Original Source(s)

A preliminary study of ECT2 as a novel biomarker for assessing liver fibrosis and prognosis in biliary atresia

  • by Yuqiang Chen, Xin Li, Qianhui Yang, Yu Meng, Alimujiang Abudureyimu, Jianghua Zhan

  • June 29, 2026

Related Content

Serum beta-2 microglobulin as a diagnostic biomarker for pediatric Epstein–Barr virus infections: a retrospective study

Case Report: A rare case of fucosidosis caused by a novel homozygous pathogenic variant in the FUCA1 gene within a 17.2 Mb region of homozygosity

Digital pathology of the living brain: a voxel-level spatio-temporal network for explainable ADHD diagnosis from raw rs-fMRI across multiple scanner sites